Gasporox Swings to Q3 Operating Loss of SEK 4.12 Million

• Gasporox swung to a third-quarter operating loss of SEK 4.12 million from a year-earlier profit of SEK 60,000.
• Net sales fell 58% year over year to SEK 3.92 million, partly due to lower sales in China.
• Cash holdings declined 28% year over year to SEK 7.5 million.
• The first LineArch was installed at a European pharmaceutical manufacturer; AutoMAP sensor field tests with a German machinery partner concluded successfully.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gasporox AB published the original content used to generate this news brief on October 22, 2026, and is solely responsible for the information contained therein.